glp-1 cirrhosis Exploring Glucagon-like Peptide-1 receptor agonist (GLP-1 RA) Use in Patients with Glucagon-like Peptide-1 Receptor Agonist Use
Description
D., Whaley, C
The cardio- and reno-protective effects of GLP-1-RA are at least in part related to the interaction with RAAS
Other than the three semaglutide injection sites (stomach, thigh, upper arm), there is no best place to inject semaglutide
Collagen Type I & III
Funding No funding
